Company Directory / research
PrivateFor profitresearchHorgen, Switzerland
CDR-Life AG
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
- Founded
- 2017 9 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $76M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
9 years old.
Reach
Website ranked #3,240,417 in the world for traffic, about 4k visits a month.
What it does
BiotechnologyOncology
Funding, as listed
$76M currency not stated
- Rounds1
- LatestSeries a, Apr 2022
- Investors3, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about CDR-Life AG, field by field. Contact details are held but never shown.
The company
- Name
- CDR-Life AG
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Christian Leisner
- Industry
- research
- Categories
- Biotechnology, Oncology
Where
- City
- Horgen
- Country
- Switzerland
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #3,240,417
- Monthly web visits
- 4,488
Funding, as listed
- Total
- 76,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Series a
- Latest round date
- Apr 2022
- Investors
- 3
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
CDR-Life AG may be growing as evidenced by the company's recent FDA clearance of an IND application for CDR404, which is a significant regulatory milestone indicating progress in their drug development pipeline. Additionally, the company has achieved a fourth milestone in collaboration with Boehringer Ingelheim for a Phase 1 trial in geographic atrophy, suggesting successful advancement in their partnership and clinical development. Furthermore, CDR-Life AG has unveiled results at AACR 2024 for T-cell engagers targeting solid tumors, demonstrating ongoing research and development efforts in the field of immuno-oncology.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Switzerland.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.